TrialCNS drugs2024

Thrombolysis with Recombinant Human Prourokinase 4.5-6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial.

Haiqing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.